Zynex Inc ZYXI

NAS: ZYXI | ISIN: US98986M1036   13/05/2024
10,68 USD (+1,81%)
(+1,81%)   13/05/2024

9 mei 2024 · Zynex to Present at the RBC Capital Markets Global Healthcare Conference · Persbericht

7 mei 2024 · Zynex Executives Recognized Among Top 25 in Medical Technology · Persbericht

30 april 2024 · Zynex Reports First Quarter 2024 Financial Results · Persbericht

18 april 2024 · Zynex Sets First Quarter 2024 Earnings Call · Persbericht

2 april 2024 · Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award · Persbericht

29 februari 2024 · Zynex Reports Fourth Quarter and Full Year 2023 Financial Results · Persbericht

22 februari 2024 · Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call · Persbericht

20 februari 2024 · Zynex Introduces New Products · Persbericht

6 februari 2024 · Zynex Receives FDA Clearance for its Next Generation NMES Device · Persbericht

2 februari 2024 · Zynex Recognized in Top 25 Medical Device Companies for 2024 · Persbericht

8 januari 2024 · Zynex to Participate at the Needham Annual Growth Conference · Persbericht

9 november 2023 · Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year · Persbericht

1 november 2023 · Zynex Announces Share Repurchase Program · Persbericht

31 oktober 2023 · Zynex Announces Review of Strategic Alternatives · Persbericht

26 oktober 2023 · Zynex Reports Third Quarter 2023 Financial Results · Persbericht

19 oktober 2023 · Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row · Persbericht

12 oktober 2023 · Zynex, Inc Sets Third Quarter 2023 Earnings Call · Persbericht

19 september 2023 · Zynex to Present at the Cantor Global Healthcare Conference · Persbericht

11 september 2023 · Zynex Announces Share Repurchase Program · Persbericht

5 september 2023 · Zynex to Present at the H.C. Wainwright Global Investment Conference · Persbericht

Mijn selecties